Strategic Acquisition ILC Dover was acquired by Ingersoll Rand in June 2024 and integrated into the Precision & Science Technologies segment, signaling potential alignment with high-value, integrated biopharma processing solutions and cross-sell opportunities within a larger industrial portfolio.

Biopharma Focus As a world leader in single-use solutions for biopharmaceutical and pharmaceutical processing, ILC Dover presents upsell potential for containment, powder handling, and aseptic transfer technologies across discovery to scale-up workflows.

WFI Launch Recent introduction of Water for Injection capabilities expands the product footprint into critical upstream/downstream water management, creating opportunities to offer complementary filtration, sanitization, and process integration services.

Expansion Signals Past restructuring and facility moves, including workforce reductions in Cork, coupled with new product launches, suggest potential for optimized supply chain solutions, transition services, and capacity-planning discussions with key operations contacts.

Tech & Partnerships Adoption of diverse tools (Power BI, Office 365, analytics) and partnerships (Flexan collaboration) indicate openness to digital process optimization, data-driven monitoring, and co-development arrangements that can be leveraged for integrated manufacturing solutions.